tretazicar has been researched along with nadp in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boland, MP; Davies, LC; Friedlos, F; Jarman, M; Knox, RJ | 1 |
Friedlos, F; Knox, RJ | 1 |
Helsby, NA; Tang, MH; Tingle, MD; Wilson, WR | 1 |
Lin, J; Wei, D; Yang, Y | 1 |
4 other study(ies) available for tretazicar and nadp
Article | Year |
---|---|
Identification of novel reduced pyridinium derivatives as synthetic co-factors for the enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC 1.6.99.2).
Topics: Animals; Aziridines; Carcinoma 256, Walker; Coenzymes; Kinetics; NAD(P)H Dehydrogenase (Quinone); NADP; Niacinamide; Nicotinamide Mononucleotide; Oxidation-Reduction; Pyridinium Compounds; Rats; Structure-Activity Relationship; Vitamin K | 1992 |
Metabolism of NAD(P)H by blood components. Relevance to bioreductively activated prodrugs in a targeted enzyme therapy system.
Topics: Animals; Antineoplastic Agents; Aziridines; Biotransformation; Blood; Blood Coagulation; Cattle; Dihydrolipoamide Dehydrogenase; Horses; Humans; Hydrolysis; Lactates; NAD; NADP; Niacinamide; Oxidation-Reduction; Prodrugs; Tumor Cells, Cultured | 1992 |
Aerobic 2- and 4-nitroreduction of CB 1954 by human liver.
Topics: Antineoplastic Agents; Aziridines; Carbon Monoxide; Chromatography, High Pressure Liquid; Clinical Trials, Phase I as Topic; Cytosol; Cytotoxins; Dicumarol; Escherichia coli; Humans; Hydroxylamines; Hypoxia; Liver; Mass Spectrometry; Microsomes, Liver; NAD; NADP; Nitroreductases; Prodrugs | 2005 |
Heterologous Overexpression and Biochemical Characterization of a Nitroreductase from Gluconobacter oxydans 621H.
Topics: Aziridines; Bacterial Proteins; Cloning, Molecular; Escherichia coli; Gluconobacter oxydans; Kinetics; NADP; Nitrobenzenes; Nitroreductases; Substrate Specificity; Trinitrotoluene | 2016 |